- Record: found
- Abstract: not found
- Article: not found
Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the phase 2 keynote-087 study [abstract 126]
P.L. Zinzani, M.A. Fanale, R Chen, P Armand, N. JOHNSON, P. BRICE, J RADFORD, V Ribrag, D. Molin, T.P. Vassilakopoulos
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.